Posted on 11/6/20
TELUS International to Acquire Lionbridge AI
LAS VEGAS--(BUSINESS WIRE)--Today, TELUS International, a digital customer experience (CX) innovator that designs, builds and delivers next-generation solutions for global and disruptive brands, announced that it . . .
Posted on 11/6/20
Epizyme Closes $150 Million Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that the company has entered into an . . .
Posted on 11/6/20
General Electric Is Back on Track Now
There are two key takeaways from General Electric's (NYSE:GE) latest earnings report. First, its industrial free cash flow (FCF) generation is going to be better in . . .
Posted on 11/6/20
How Bristol Myers Squibb Beat Wall Street Estimates in Q3
Bristol Myers Squibb (NYSE:BMY) hasn't been a big winner for investors so far this year. And that's despite the big drugmaker having some pretty good news . . .
Posted on 11/6/20
Biogen Changes The World And Grows 44%
SummaryBiogen had a dramatic day, after years of flip-flop, as it appears the company's new Aducanumab drug will be approved.Even outside of Aducanumab, the company has . . .
Posted on 11/6/20
Why Akamai Stock Dropped Nearly 14% in October
What happenedShares of Akamai Technologies (NASDAQ:AKAM) dropped 13.9% in October, according to data provided by S&P Global Market Intelligence. Most of the drop came after the . . .
Posted on 11/6/20
3 Reasons Raytheon Technologies Is a Good Value Stock
Raytheon Technologies (NYSE:RTX) CEO Greg Hayes closed the third-quarter earnings call by reminding investors that two-thirds of the company's current revenue is defense related, and it . . .
Posted on 11/6/20
Entasis Therapeutics Provides a Business Update
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel . . .
Posted on 11/6/20
Sarepta Therapeutics Announces Recent Corporate Developments
CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for . . .
Posted on 11/6/20
Ziopharm Oncology Provides Corporate Update
BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced its financial results for the third quarter ended September 30, 2020 and . . .
Posted on 11/6/20
Adicet Provides Business Update
MENLO PARK, Calif. and BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta . . .
Posted on 11/6/20
Thermo Fisher Scientific Authorizes $2.5B of Share Repurchases
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.22 . . .
Posted on 11/6/20
Ironwood Pharmaceuticals Appoints Alexander Denner to Board of Directors
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the appointment of Alexander Denner, Ph.D., to its Board of Directors, effective November 9, 2020.
Posted on 11/6/20
Pacific Defense Acquires Spear Research
Pacific Defense announces the acquisition of Spear Research, a Nashua, New Hampshire based technology company focused
Posted on 11/5/20
Marcus & Millichap Brokers $26.5 Million Sale of the Amesbury Collection
Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of . . .
Posted on 11/5/20
Starwood Property Trust Reports Results for the Quarter
Starwood Property Trust, Inc. (NYSE: STWD) today announced operating results for the fiscal quarter ended September 30, 2020. The Company's third quarter 2020 GAAP net income . . .
Posted on 11/5/20
Cigna Reports Third Quarter 2020 Performance
Global health services company Cigna Corporation (NYSE: CI) today reported solid third quarter 2020 performance led by strong execution by its Evernorth segment."In these dynamic and . . .
Posted on 11/5/20
Koch Separation Solutions Acquires RELCO
Koch Separation Solutions (KSS), a global leader in separation technology, today announced the acquisition of RELCO, a top provider of cutting-edge process technologies for the dairy . . .
Posted on 11/5/20
Eze Castle Integration Acquires NorthOut
Eze Castle Integration, a portfolio company of private equity investment firm H.I.G. Capital and a global leader in technology solutions, today announced the acquisition of digital . . .
Posted on 11/5/20
Curaleaf Completes Acquisition of Alternative Therapies Group's Cultivation and Processing Operations
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States,
Posted on 11/5/20
Liberty Mutual Insurance Reports Third Quarter 2020 Results
Liberty Mutual Holding Company Inc. and its subsidiaries reported net income attributable to LMHC of $397 million and $596 million for the three and nine months . . .
Posted on 11/5/20
Akebia Reports Third Quarter 2020 Financial Results
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for . . .
Posted on 11/5/20
Navisite Acquires Dickinson + Associates
Navisite today announced its acquisition of Dickinson + Associates, an SAP consulting firm based in Chicago. As a Premier SAP Gold Partner with over 22 years . . .
Posted on 11/5/20
Houghton Mifflin Harcourt Announces Third Quarter 2020 Results
Learning technology company Houghton Mifflin Harcourt (Nasdaq: HMHC) today announced financial results for the quarter ended September 30, 2020. The Company also announced its intent to explore . . .
Posted on 11/5/20
Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today reported . . .

